Biologics Approval Time Drops To 19 Months In 2001
Executive Summary
The average approval time for a new therapeutic/ vaccine biologic application in 2001 was 19 months, a five-month improvement over 2000
You may also be interested in...
FDA Drug Approval Time Edges Up To 18.5 Months In 2001
The average NDA approval time is still about a year and a half, an analysis of new molecular entities cleared by FDA in 2001 shows
CBER User Fee Standards May Need To Differ From CDER's, Director Zoon Says
The Center for Biologics Evaluation & Research may need a different set of user fee review parameters than the drug center, CBER Director Kathryn Zoon, PhD, suggested during a Dec. 7 FDA public meeting on the Prescription Drug User Fee Act
Lilly Xigris Price Is $6,800 Per Dose; Sepsis Agent Clears FDA
Lilly's sepsis agent Xigris will be priced at an average net wholesale price of $6,800 per 96-hour course of therapy, depending on the weight of the patient